Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy

doi:10.3748/wjg.v21.i39.11168

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 39

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7967)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

492

WORD

263

HTML

3984

Figures (1-6)

194

Tables (1-2)

272

Sum=5205

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1049

Download

1713

Sum=2762

Oct 21, 2015 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. Oct 21, 2015; 21(39): 11168-11178
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.11168

Full Size Figure Download Figure

Figure 4 Plasma interleukin-6 levels in pancreatic ductal adenocarcinoma patients receiving chemoimmunotherapy. A: Plasma interleukin (IL)-6 levels in 6 patients during treatment; B: Comparison of plasma IL-6 levels prior to treatment between super-responders [overall survival (OS) ≥ 1 year] and nonsuper-responders (OS < 1 year); C: Comparison of plasma IL-6 levels in super-responders prior to treatment and post-vaccination; D: Comparison of plasma IL-6 levels after 5 vaccinations between nonsuper-responders and super-responders after 5, 10, 15, 20, and 25 vaccinations. The values are expressed as mean ± SD. ^aP < 0.05.

Citation: Tsukinaga S, Kajihara M, Takakura K, Ito Z, Kanai T, Saito K, Takami S, Kobayashi H, Matsumoto Y, Odahara S, Uchiyama K, Arakawa H, Okamoto M, Sugiyama H, Sumiyama K, Ohkusa T, Koido S. Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy. World J Gastroenterol 2015; 21(39): 11168-11178
URL: https://www.wjgnet.com/1007-9327/full/v21/i39/11168.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i39.11168